Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 248.21 |
| Open | 251.04 |
| Bid | 0.00 x 1400 |
| Ask | 0.00 x 1000 |
| Day's Range | 250.00 - 260.52 |
| 52 Week Range | 181.36 - 349.84 |
| Volume | |
| Avg. Volume | 591,951 |
| Market Cap | 13.224B |
| Beta (5Y Monthly) | 1.32 |
| PE Ratio (TTM) | 29.98 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Charles River (CRL) to Report Q4 Earnings: What's in Store?
The broad-based demand and meaningful price increases in the RMS business particularly in North America are expected to have contributed to Charles River's (CRL) top line in Q4.
- Zacks
Charles River's (CRL) New CDMO Tie-Up to Boost Clinical Trials
Charles River's (CRL) latest partnership is expected to bring a potentially curative therapy, RZ-001, to HCC patients.
- Zacks
Charles River (CRL) to Develop RNA-based Therapy With New Pact
Charles River's (CRL) new partnership will enable the clinical development of RNA-based anticancer gene therapy in liver cancer patients.
© 2023 Yahoo. All rights reserved.
